Home / Press / Synlab and FutureLAB: CMS Hasche Sigle advises BC...

Synlab and FutureLAB: CMS Hasche Sigle advises BC Partners on investment in lab service providers

03/09/2009

Stuttgart – CMS Hasche Sigle advised BC Partners, a worldwide active Private Equity-Firm, on its investment in leading lab service providers. Funds advised by BC Partners ("BC Partners") have reached agreement with the shareholders on taking a 40% stake in laboratory-testing company Synlab and acquiring FutureLAB.

The two lab chains provide services, analysis and consulting for human and veterinary medicine in a range of countries and also cover the environmental field. Augsburg-based lab service provider Synlab operates in a total of 18 countries, with 55 of the 73 locations worldwide being in Germany. The company employs some 2,000 people. FutureLAB has more than 120 locations in 7 countries (Germany, Austria, Romania, Switzerland, Slovakia, Czech Republic, Hungary). Synlab and FutureLAB jointly employ more than 4000 people and have a turnover of approximately EUR 380 million.

BC Partners was advised on this cross-border transaction by an international team drawn from several law firms within the CMS organisation and led by Dr Udo Simmat, CMS Hasche Sigle partner and private equity expert.

BC Partners is a leading European private equity firm, operating out of offices in London, Hamburg, Paris, Geneva, Milan and New York. In the 20 years since the firm was established, the funds advised by BC Partners have invested in 69 companies with a combined enterprise value of EUR 65 billion.

Advisor CMS Hasche Sigle:

  • Dr. Udo Simmat, Private Equity (Lead Partner)
  • Dr. Claus-Peter Fabian
  • Dr. Eva Annett Grigoleit
  • Dr. Tobias Schneider
  • Dr. Jörg Zätzsch
  • Jesko Nobiling (all M & A)
  • Dr. Gerd Leutner (Due Diligence / Corporate)
  • Dr. Andreas Bohnenkamp
  • Dr. Florian Hofer
  • Dr. Christoph Lächler
  • Christian Plodeck
  • Dr. Jens Rudolph
  • Dr. Jacob Siebert
  • Jill Theuring, (all Corporate / M&A / Due Diligence)
  • Dr. Ulrich Thiem (Due Diligence)
  • Dr. Alexandra Schluck-Amend (Commercial)
  • Dr. Marc Riede
  • Dr. Anja Hasselmann-Thiede
  • Julia Runge (all Banking & Finance)
  • Dr. Harald Kahlenberg
  • Dr. Rolf Hempel
  • Dr. Mathias Traub
  • Christian Treib, (all Antitrust)
  • Dr. Ursula Steinkemper, (Procurement)
  • Dr. Björn Otto
  • Andreas Hofelich (Labor)
  • Dr. Axel Funk (IT)

Advisor CMS Reich-Rohrwig Hainz (Austria):

  • Dr. Günther Hanslik (Corporate / M&A)
  • Dr. Bernt Elsner
  • Mag. Robert Keisler (Antitrust)
  • Mag. Anna Konopka (Corporate / M&A)

Advisor CMS von Erlach Henrici (Switzerland):

  • Alain Raemy (Antitrust)
  • Martin Wyser (Corporate / M& A)
  • Dr. Clemens von Zedtwitz (Antitrust, Regulatory)

Advisor CMS Cameron McKenna LLP (Czech Republic):

  • Richard Bacek
  • Helen Rodwell
  • Evana Fara
  • Radmin Kotlaba

Advisor CMS Cameron McKenna LLP, (Hungary):

  • Zoltan Poronyi
  • Agnes Benko

Further involved law firms are located in the countries: Azerbaijan, Macedonia, Slovakia, Turkiye and Belarus.

Contact:

Dr Udo Simmat
Tel.: +49 (0) 711 / 97 64–363
E-Mail: Udo.Simmat@cms-hs.com

Press releases
090903_PM_BCPartners_Synlab_en
Download
PDF 215.9 kB

Related people

Portrait ofRolf Hempel
Dr. Rolf Hempel
Partner
Stuttgart
Portrait ofGerd Leutner
Dr. Gerd Leutner
Partner
Berlin
Portrait ofEva Annett Grigoleit
Dr. Eva Annett Grigoleit
Partner
Berlin
Portrait ofAlexandra Schluck-Amend
Dr. Alexandra Schluck-Amend
Partner
Stuttgart
Portrait ofHarald Kahlenberg
Dr. Harald Kahlenberg
Partner
Stuttgart
Show more Show less